Global Branded Products

Global Branded Products

Specialty Products

Central Nervous System (CNS)


Reduction of the frequency of relapses in patients with Relapsing-Remitting Multiple Sclerosis (RRMS), including patients who have experienced a first clinical episode and have MRI features consistent with multiple sclerosis.


Treatment of the signs and symptoms of Parkinson’s disease (PD) as initial monotherapy and as adjunct therapy to levodopa.



Improve wakefulness in patients with excessive sleepiness associated with obstructive sleep apnea (OSA) shift work disorder (SWD) and narcolepsy.



Improve wakefulness in patients with excessive sleepiness associated with obstructive sleep apnea (OSA) shift work disorder (SWD) and narcolepsy.



Adjunctive treatment of partial seizures in epileptic patients.

Women's Health


A 91 day ascending-dose, extended-regimen oral contraceptive for the prevention of pregnancy



28-day (24/4) monophasic regimen oral contraceptive containing natural 17-β estradiol with nomegestrol acetate


PLAN B One-Step

Prevention of pregnancy following unprotected intercourse or a known or suspected contraceptive failure (to be taken within 72 hours).


(1) Treatment of moderate to severe vasomotor symptoms associated with menopause.  
(2) Treatment of moderate to severe vaginal dryness and pain with intercourse, symptoms of vulvar and vaginal atrophy, associated with menopause.


Oral contraceptive for use of women to prevent pregnancy.



For intrauterine contraception for up to 10 years.




(1) Maintenance treatment of asthma as prophylactic therapy.
(2) For asthma patients who require systemic corticosteroid administration, where adding QVAR may reduce or eliminate the need for the systemic corticosteroids.

ProAir HFA

(1) For the treatment or prevention of bronchospasm in patients with reversible obstructive airway disease.
(2) For the prevention of exercise-induced bronchospasm.


QNASL (beclomethasone dipropionate)

Nasal Aerosol is indicated for the treatment of nasal symptoms associated with seasonal and perennial allergic rhinitis in adults and adolescents 12 years of age and older.



Management of breakthrough cancer pain.


Management of breakthrough cancer pain.



Muscle spasm associated with acute, painful musculoskeletal conditions.



(1)Chronic Lymphocytic Leukemia (CLL)
(2)Non-Hodgkin's Lymphoma (NHL).


Induction of remission and consolidation for acute promyelocytic leukemia (APL).



For the reduction in the duration of neutropenia and the incidence of febrile neutropenia in patients treated with established cytotoxic chemotherapy for malignancy and in patients undergoing myeloablative therapy followed by bone marrow transplantation. For the mobilisation of peripheral blood progenitor cells (PBPC). For the treatment of persistent neutropenia in patients with advanced HIV infection.



Treatment of symptomatic anaemia associated with chronic renal failure in adult patients and treatment of symptomatic anaemia in adult cancer patients with non-myeloid malignancies receiving chemotherapy.


SYNRIBO™ (omacetaxine mepesuccinate) for Injection

For the treatment of adult patients with chronic or accelerated phase chronic myeloid leukemia (CML) with resistance and/or intolerance to two or more tyrosine kinase inhibitors (TKIs). This indication is based upon response rate. There are no trials verifying an improvement in disease-related symptoms or increased survival with SYNRIBO.